Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12767014rdf:typepubmed:Citationlld:pubmed
pubmed-article:12767014lifeskim:mentionsumls-concept:C0085274lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C0033011lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C0003320lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C0079189lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:12767014lifeskim:mentionsumls-concept:C2348480lld:lifeskim
pubmed-article:12767014pubmed:issue3lld:pubmed
pubmed-article:12767014pubmed:dateCreated2003-5-26lld:pubmed
pubmed-article:12767014pubmed:abstractTextParvovirus B19 infection is a significant cause of fetal death. The aim of this study was to investigate the role of maternal immune status in modulating susceptibility to fetal B19 infection. Peripheral blood was obtained from pregnant women (n = 199) with no clinical evidence of recent B19 infection. Evaluation of ex vivo T cell responses from 149/199 individuals showed significantly higher interferon-gamma levels for seropositive individuals following VP1 (268 +/- 36 versus 103 +/- 19 pg/ml; P = 0.003) and VP2 (242 +/- 42 versus 91 +/- 16 pg/ml; P = 0.01) antigen stimulation. Significantly higher levels of interleukin-2 were also observed in seropositive individuals following both VP1 (P = 0.0003) and VP2 (P = 0.0005) stimulation. The observed Th1 cellular response is lower than that documented previously for non-pregnant individuals and strongly suggests that diminution of the maternal anti-viral immune response may increase susceptibility to fetal B19 infection.lld:pubmed
pubmed-article:12767014pubmed:languageenglld:pubmed
pubmed-article:12767014pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:citationSubsetIMlld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12767014pubmed:statusMEDLINElld:pubmed
pubmed-article:12767014pubmed:monthJullld:pubmed
pubmed-article:12767014pubmed:issn0146-6615lld:pubmed
pubmed-article:12767014pubmed:authorpubmed-author:DoyleSeanSlld:pubmed
pubmed-article:12767014pubmed:authorpubmed-author:DavorenAnneAlld:pubmed
pubmed-article:12767014pubmed:authorpubmed-author:McParlandPete...lld:pubmed
pubmed-article:12767014pubmed:authorpubmed-author:CorcoranAmand...lld:pubmed
pubmed-article:12767014pubmed:authorpubmed-author:MahonBernard...lld:pubmed
pubmed-article:12767014pubmed:copyrightInfoCopyright 2003 Wiley-Liss, Inc.lld:pubmed
pubmed-article:12767014pubmed:issnTypePrintlld:pubmed
pubmed-article:12767014pubmed:volume70lld:pubmed
pubmed-article:12767014pubmed:ownerNLMlld:pubmed
pubmed-article:12767014pubmed:authorsCompleteYlld:pubmed
pubmed-article:12767014pubmed:pagination475-80lld:pubmed
pubmed-article:12767014pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:meshHeadingpubmed-meshheading:12767014...lld:pubmed
pubmed-article:12767014pubmed:year2003lld:pubmed
pubmed-article:12767014pubmed:articleTitleEx vivo cytokine responses against parvovirus B19 antigens in previously infected pregnant women.lld:pubmed
pubmed-article:12767014pubmed:affiliationBiotechnology Group, Department of Biology, National University of Ireland, Maynooth, Co. Kildare, Ireland.lld:pubmed
pubmed-article:12767014pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12767014pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12767014pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:12767014pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12767014lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12767014lld:pubmed